MUMBAI Nov 5 Cipla Ltd, India's third-largest drugmaker by sales, reported a second-quarter net profit slightly below analysts estimates, as expenses rose.
Net profit rose 44 percent to 4.31 billion rupees ($65.56 million) in the quarter ended September, Cipla said in a statement on Thursday. But it was below analysts' average estimate of 4.84 billion rupees, according to Thomson Reuters data.
09:43 Austria sues Airbus, Eurofighter consortium over suspected fraud18
18:46 Verizon Slashes Price of Yahoo Deal by at Least $250 Million: Bloomberg20
21:36 Berkshire takes huge bite of Apple shares, ups stakes in airlines18
14:37 T-Mobile U.S. quarterly revenue, profit beat estimates19